Novartis to sell transfusion diagnostics unit

Novartis is to sell its blood transfusion diagnostics unit, acquired in 2006 as part of Chiron Corp, to the Spain-based company Grifols SA for $1.7 billion. The transaction is expected to be completed in the first half of 2014.